Car t cell immunotherapy for human cancer

Cited by (1,007)

Items 101–200 of 1,007

1. Advancements and challenges in CAR T cell therapy in autoimmune diseases
   G. Schett, F. Müller, J. Taubmann, A. Mackensen, Wei Wang, Rich A. Furie, Ralf Gold, A. Haghikia, P. Merkel, Roberto Caricchio et al. · 2024 · Nature Reviews Rheumatology
2. Macroscale biomaterials strategies for local immunomodulation
   Maxence O. Dellacherie, Bo Ri Seo, David J. Mooney · 2019 · Nature Reviews Materials
3. Clinical cancer immunotherapy: Current progress and prospects
   Chenglong Liu, Mengxuan Yang, Daizhou Zhang, Ming Chen, Di Zhu · 2022 · Frontiers in Immunology
4. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
   Naval Guastad Daver, Ahmad S. Alotaibi, Veit Bücklein, Marion S. Subklewe · 2021 · Leukemia
5. Cell Therapy: Types, Regulation, and Clinical Benefits
   El-Kadiry, Abed El-Hakim, Rafei, Moutih, Shammaa, Riam · 2021 · Frontiers in Medicine
6. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies
   Hongjian Li, Kun Peng, Kai Yang, Wenbo Ma, Shaolong Qi, Xinyang Yu, Jia He, Xin Lin, Guocan Yu · 2022 · Theranostics
7. Genetically engineered T cells for cancer immunotherapy
   Dan Li, Xue Li, Wei-Lin Zhou, Yong Huang, Xiao Liang, Lin Jiang, Xiao Yang, Jie Sun, Zonghai Li, Weidong Han et al. · 2019 · Signal Transduction and Targeted Therapy
8. Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
   Chong-xian Pan, Hongtao Liu, Elizabeth Robins, Wenru Song, Delong Liu, Zihai Li, Lei Zheng · 2020 · Journal of Hematology & Oncology
9. Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy
   Shuang Liang, Jianjun Yao, Dan Liu, Lang Rao, Xiaoyuan Shawn Chen, Zhaohui Wang · 2023 · Advanced Materials
10. Cell membrane coated-nanoparticles for cancer immunotherapy
    Zeng, Yingping, Li, Sufen, Zhang, Shufen, Wang, Li, Yuan, Hong, Hu, Fuqiang · 2022 · Acta Pharmaceutica Sinica B
11. Trial Watch: Toll-like receptor agonists in cancer immunotherapy
    Melody M. Smith, Elena García-Martínez, Michael Reginald Pitter, Jitka Palich Fucikova, Radek Špíšek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2018 · OncoImmunology
12. Advances in Glioblastoma Therapy: An Update on Current Approaches
    Ramcharan Singh Angom, Naga Malleswara Rao Nakka, Santanu Bhattacharya · 2023 · Brain Sciences
13. CAR T cells for infection, autoimmunity and allotransplantation
    Colby R. Maldini, Gavin I. Ellis, James L. Riley · 2018 · Nature reviews. Immunology
14. The landscape of bispecific T cell engager in cancer treatment
    Shujie Zhou, Mingguo Liu, Fei Ren, Xiangjiao Meng, Jinming Yu · 2021 · Biomarker Research
15. CAR-T: What Is Next?
    Yi–Ju Chen, Bams Abila, Yasser Mostafa Kamel · 2023 · Cancers
16. Patient-derived micro-organospheres enable clinical precision oncology
    Ding, Shengli, Hsu, Carolyn, Wang, Zhaohui, Natesh, Naveen R., Millen, Rosemary, Negrete, Marcos, Giroux, Nicholas, Rivera, Grecia O., Dohlman, Anders, Bose, Shree et al. · 2022 · Cell Stem Cell
17. CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
    Margery Gang, Nancy D. Marín, Pamela Wong, Carly C. Neal, Lynne I. Marsala, Mark Foster, Timothy Schappe, Wei Meng, Jennifer Tran, Maximilian O. Schaettler et al. · 2020 · Blood
18. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
    Alexandra Schnell, Lloyd Bod, Asaf Madi, Vijay Kumar Kuchroo · 2020 · Cell Research
19. Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
    Shuhang Wang, Jingwei Sun, Kun Chen, Peiwen Ma, Qi Lei, Shujun Xing, Zhongzheng Cao, Shujun Sun, Zicheng Yu, Yarong Liu et al. · 2021 · BMC Medicine
20. Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
    Junyun Lai, Sherly Mardiana, Imran G. House, Kevin Sek, Melissa A. Henderson, Lauren Giuffrida, Amanda X.Y. Chen, Kirsten L. Todd, Emma V. Petley, Jack D. Chan et al. · 2020 · Nature Immunology
21. Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
    May Daher, Katayoun Rezvani · 2020 · Cancer Discovery
22. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing
    Fadi Jacob, Guo‐li Ming, Hongjun Song · 2020 · Nature Protocols
23. Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
    Nathalie Scholler, Régis Perbost, Frederick Lundry Locke, Michael David Jain, Sarah Turcan, Corinne Danan, Edmund C. Chang, Sattva Swarup Neelapu, David Bernard Miklos, Caron Alyce Jacobson et al. · 2022 · Nature Medicine
24. Engineering cytokine therapeutics
    Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, Anne de Dreu, David P. Schrijver, Koen de Bruin, Yohana C. Toner, Thijs J. Beldman, Jamie B. Spangler, Tom F. A. de Greef et al. · 2023 · Nature Reviews Bioengineering
25. Designing Cancer Immunotherapies That Engage T Cells and NK Cells
    Oleksandr Kyrysyuk, Kai W. Wucherpfennig · 2022 · Annual Review of Immunology
26. De novo design of protein logic gates
    Zibo Chen, Ryan D. Kibler, Andrew C. Hunt, Florian Büsch, Jocelynn R. Pearl, Mengxuan Jia, Zachary L. VanAernum, Basile I. M. Wicky, Galen Dods, Hanna Liao et al. · 2020 · Science
27. Biological drug and drug delivery-mediated immunotherapy
    Qingqing Xiao, Xiaotong Li, Yi Li, Zhenfeng Wu, Chenjie Xu, Zhongjian Chen, Wei He · 2020 · Acta Pharmaceutica Sinica B
28. Recent advances in systemic therapy for hepatocellular carcinoma
    Huajun Zhang, Wuyang Zhang, Longying Jiang, Yongheng Chen · 2022 · Biomarker Research
29. Responsive biomaterials: optimizing control of cancer immunotherapy
    Lulu Xue, Ajay S. Thatte, David Mai, Rebecca M. Haley, Ningqiang Gong, Xuexiang Han, Karin Wang, Neil C. Sheppard, Carl H. June, Michael J. Mitchell · 2023 · Nature Reviews Materials
30. In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
    Anett Pfeiffer, Frederic B. Thalheimer, Sylvia Hartmann, Annika M. Frank, Ruben R Bender, Simon Danisch, Caroline Costa, Winfried S. Wels, Ute Modlich, Renata Stripecke et al. · 2018 · EMBO Molecular Medicine
31. Engineering patient-specific cancer immunotherapies
    Scheetz, Lindsay, Park, Kyung Soo, Li, Qiao, Lowenstein, Pedro R., Castro, Maria G., Schwendeman, Anna, Moon, James J. · 2019 · Nature Biomedical Engineering
32. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review
    Bingren Tian, Shiyao Hua, Jiayue Liu · 2019 · Carbohydrate Polymers
33. Immunosenescence, aging and successful aging
    Yunan Wang, Dong Chen, Yudian Han, Zhifeng Gu, Chi Chin Sun · 2022 · Frontiers in Immunology
34. Viral Vector-Based Gene Therapy
    Xuedan Li, Yang Le, Zhegang Zhang, Xuanxuan Nian, Бо Лю, Xiaoming Yang · 2023 · International Journal of Molecular Sciences
35. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
    Gunjan Dagar, Ashna Gupta, Tariq Masoodi, Sabah Nisar, Maysaloun Merhi, Sheema Hashem, Ravi Chauhan, Manisha Dagar, Sameer Mirza, Puneet Bagga et al. · 2023 · Journal of Translational Medicine
36. Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
    Xingliang Guo, Hua Jiang, Bizhi Shi, Min Zhou, Honghong Zhang, Zhimin Shi, Guoxiu Du, Hong Luo, Xiuqi Wu, Yi Wang et al. · 2018 · Frontiers in Pharmacology
37. CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Karan L. Chohan, Elizabeth L. Siegler, Saad S. Kenderian · 2023 · Current Hematologic Malignancy Reports
38. Mechanosensing through immunoreceptors
    Cheng Zhu, Wei Chen, Jizhong Lou, William Rittase, Kaitao Li · 2019 · Nature Immunology
39. Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
    Xiangyuan Luo, Kongming Wu, Xingxing He · 2021 · Journal of Experimental & Clinical Cancer Research
40. A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
    Lupeng Ye, Jonathan Joon-Young Park, Lei Peng, Quanjun Yang, Ryan Dz-Wei Chow, Matthew B. Dong, Stanley Z. Lam, Jianjian Guo, Erting Tang, Yueqi Zhang et al. · 2022 · Cell Metabolism
41. Platelet for drug delivery
    Yifei Lü, Quanyin Hu, Chen Jiang, Zhen Gu · 2018 · Current Opinion in Biotechnology
42. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
    Shan Gao, Dongjuan Yang, Yan Fang, Xiaojie Lin, Xuechao Jin, Qi Wang, Xiyan Wang, Liyuan Ke, Kai Shi · 2018 · Theranostics
43. Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety
    Nhung T. Nguyen, Kai Huang, Hongxiang Zeng, Jing Ji, Rui Ying Wang, Shaohai Fang, Joyce Chen, Xin Liu, Zixian Huang, Mingjian James You et al. · 2021 · Nature Nanotechnology
44. Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
    Xiao Han, Yao Wang, Jianshu Wei, Weidong Han · 2019 · Journal of Hematology & Oncology
45. Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis
    Rongqing Aaron Pan, Jeremy A. Ryan, Deng Pan, Kai W. Wucherpfennig, Anthony G. Letai · 2022 · Cell
46. Metabolism in tumor microenvironment: Implications for cancer immunotherapy
    Rongchen Shi, Yi‐Quan Tang, Hongming Miao · 2020 · MedComm
47. Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
    Song, Ping, An, Junqing, Zou, Ming-Hui · 2020 · Cells
48. Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
    Diego A. Ellerman · 2018 · Methods
49. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
    Tseng Hsiang-Chi, Wei Xiong, Saiaditya Badeti, Yan Yang, Minh Ma, Ting Liu, Carlos A. Ramos, Gianpietro Dotti, Luke Fritzky, Jie-gen Jiang et al. · 2020 · Nature Communications
50. Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
    Mark Sweeney, Ben Corden, Stuart A. Cook · 2020 · EMBO Molecular Medicine
51. Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
    Qin Fu Feng, Bin He · 2019 · Frontiers in Oncology
52. Review of Functionalized Nanomaterials for Photothermal Therapy of Cancers
    Wangqing Bian, Ya‐Kun Wang, Zhenxing Pan, Niping Chen, Xiaojing Li, Wing‐Leung Wong, Xujie Liu, Yan He, Kun Zhang, Yu‐Jing Lu · 2021 · ACS Applied Nano Materials
53. The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
    Wenxiao Jia, Qianqian Gao, Anqin Han, Hui Zhu, Jinming Yu · 2019 · Cancer Biology and Medicine
54. Precision medicine for human cancers with Notch signaling dysregulation (Review)
    Masuko Katoh, Masaru Katoh · 2019 · International Journal of Molecular Medicine
55. Gene editing and CRISPR in the clinic: current and future perspectives
    Matthew P. Hirakawa, Raga Krishnakumar, Jerilyn A. Timlin, James P. Carney, Kimberly S. Butler · 2020 · Bioscience Reports
56. Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
    Jefte M. Drijvers, Jacob E. Gillis, Tara Muijlwijk, Thao H. Nguyen, Emily F. Gaudiano, Isaac S. Harris, Martin W. LaFleur, Alison Epstein Ringel, Cong-Hui Yao, Kiran Kurmi et al. · 2020 · Cancer Immunology Research
57. Engineered skin bacteria induce antitumor T cell responses against melanoma
    Chen, Y. Erin, Bousbaine, Djenet, Veinbachs, Alessandra, Atabakhsh, Katayoon, Dimas, Alex, Yu, Victor K., Zhao, Aishan, Enright, Nora J., Nagashima, Kazuki, Belkaid, Yasmine et al. · 2023 · Science
58. Correlate tumor mutation burden with immune signatures in human cancers
    Xiaosheng Wang, Mengyuan Li · 2019 · BMC Immunology
59. In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes
    Shiwani Agarwal, Julia D.S. Hanauer, Annika M. Frank, Vanessa Riechert, Frederic B. Thalheimer, Christian J. Buchholz · 2020 · Molecular Therapy
60. Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements
    Shah, Nakul M., Jang, H. Josh, Liang, Yonghao, Maeng, Ju Heon, Tzeng, Shin-Cheng, Wu, Angela, Basri, Noah L., Qu, Xuan, Fan, Changxu, Li, Amy et al. · 2023 · Nature Genetics
61. Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
    Ying Yang, Andreas Lundqvist · 2020 · Cancers
62. CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
    Hannah M. Knochelmann, Aubrey S. Smith, Connor J. Dwyer, Megan M. Wyatt, Shikhar Mehrotra, Chrystal Mary Paulos · 2018 · Frontiers in Immunology
63. Biomedical polymers: synthesis, properties, and applications
    Wei‐Hai Chen, Qi‐Wen Chen, Qian Chen, Chunyan Cui, Shun Duan, Yongyuan Kang, Yang Liu, Yun Liu, Wali Muhammad, Shiqun Shao et al. · 2022 · Science China Chemistry
64. Translational genomics and precision medicine: Moving from the lab to the clinic
    Eleftheria Zeggini, Anna L. Gloyn, Anne C Barton, Louise V. Wain · 2019 · Science
65. Nanobody-based CAR-T cells for cancer immunotherapy
    Pouya Safarzadeh Kozani, Abdolhossein Naseri, Seyed Mohamad Javad Mirarefin, Faeze Salem, Mojtaba Nikbakht, Sahar Evazi Bakhshi, Pooria Safarzadeh Kozani · 2022 · Biomarker Research
66. The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth
    Pengxiang Yang, Xingjian Cao, Huilong Cai, Pan-Feng Feng, Xiang 'Anthony' Chen, Yihua Zhu, Yue Yang, Weiwei An, Yumin Yang, Jing Jie · 2020 · Cellular Immunology
67. New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
    Tejeshwar Jain, Prateek Sharma, Abhi C. Are, Selwyn Maurice Vickers, Vikas Dudeja · 2021 · Frontiers in Immunology
68. Dynamics and competition of CRISPR–Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing
    Ya-Wen Fu, Xinyue Dai, Wentian Wang, Zhi-Xue Yang, Juan-Juan Zhao, Jianping Zhang, Wei Wen, Feng Zhang, Kerby C. Oberg, Lei Zhang et al. · 2020 · Nucleic Acids Research
69. Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
    Benno Lickefett, Lulu Chu, Valentín Ortiz‐Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, David Andrew Henderson, Michael Hudecek, Andreas Kremer, Janet L. Markman et al. · 2023 · Frontiers in Immunology
70. Dormant tumour cells, their niches and the influence of immunity
    Erica T. Goddard, Ivana Božić, Stanley R. Riddell, Cyrus Michael Ghajar · 2018 · Nature Cell Biology
71. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment
    Jie Cheng, Jinxin Yan, Ying Liu, Jiangzhou Shi, Haoyu Wang, Hanyang Zhou, Ying‐Lin Zhou, Tongcun Zhang, Lina Zhao, Xianbin Meng et al. · 2023 · Cell Metabolism
72. Nanomaterials for photothermal cancer therapy
    Shufan Duan, Yanling Hu, Ying Ru Zhao, Kaiyuan Tang, Zhijing Zhang, Zilu Liu, Ying Wang, Haiyang Guo, Yuchen Miao, Hengda Du et al. · 2023 · RSC Advances
73. Delivery strategies of cancer immunotherapy: recent advances and future perspectives
    Zhongwei Zhao, Liyun Zheng, Weiqian Chen, Wei Weng, Jingjing Song, Jiansong Ji · 2019 · Journal of Hematology & Oncology
74. CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
    Fabio Morandi, Alberto L. Horenstein, Federica Costa, Nicola Giuliani, Vito Pistoia, Fabio Malavasi · 2018 · Frontiers in Immunology
75. FLT3 inhibitors in acute myeloid leukemia
    Mei‐Hwan Wu, Chuntuan Li, Xiongpeng Zhu · 2018 · Journal of Hematology & Oncology
76. Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
    Amy L. Shergold, Rhona Millar, Robert J. B. Nibbs · 2019 · Pharmacological Research
77. Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
    Wilkinson, Holly N., Hardman, Matthew J. · 2020 · Frontiers in Cell and Developmental Biology
78. Targeted Immunotherapy for Autoimmune Disease
    Seung Min Jung, Wan‐Uk Kim · 2022 · Immune Network
79. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment
    Zehang Jiang, Zhixian Liu, Mengyuan Li, Cai Chen, Xiaosheng Wang · 2019 · EBioMedicine
80. Recent advances in microfluidic platforms for single-cell analysis in cancer biology, diagnosis and therapy
    Hamed Tavakoli, Wan Zhou, Lei Ma, Stefani Perez, Andrea Ibarra, Feng Xu, Sihui Zhan, Xiujun Li · 2019 · TrAC Trends in Analytical Chemistry
81. The Diversification of Cell Death and Immunity: Memento Mori
    Arnaud J. Legrand, Maria Konstantinou, E. Goode, Pascal Meier · 2019 · Molecular Cell
82. Linking macrophage metabolism to function in the tumor microenvironment
    Robbie Jin, Luke A. Neufeld, Tracy L. McGaha · 2025 · Nature Cancer
83. PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges
    Eileen M. McGowan, Qimou Lin, Guocai Ma, Haibin Yin, Size Chen, Yiguang Lin · 2019 · Biomedicine & Pharmacotherapy
84. RNA Nanotechnology-Mediated Cancer Immunotherapy
    Yao‐Xin Lin, Yi Wang, Sara Blake, Mian Yu, Lin Mei, Hao Wang, Jinjun Shi · 2019 · Theranostics
85. CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?
    Jason R. Westin, Laurie Helen Sehn · 2022 · Blood
86. The Notch signaling pathway: a potential target for cancer immunotherapy
    Xinxin Li, Xianchun Yan, Yufeng Wang, Balveen Kaur, Hua Han, Jianhua Yu · 2023 · Journal of Hematology & Oncology
87. Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry
    Wenzhe Yi, Ping Xiao, Xiaochen Liu, Zitong Zhao, Xiangshi Sun, Jue Wang, Lei Zhou, Guanru Wang, Haiqiang Cao, Dangge Wang et al. · 2022 · Signal Transduction and Targeted Therapy
88. Macrophage targeting: opening new possibilities for cancer immunotherapy
    Luca Cassetta, Takanori Kitamura · 2018 · Immunology
89. Technological advances in cancer immunity: from immunogenomics to single‐cell analysis and artificial intelligence
    Xu, Ying, Su, Guan-Hua, Ma, Ding, Xiao, Yi, Shao, Zhi-Ming, Jiang, Yi-Zhou · 2021 · Signal Transduction and Targeted Therapy
90. Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma
    Peng Zhang, Jason M. Miska, Catalina Lee-Chang, Aida Rashidi, Wojciech K. Panek, Shejuan An, Μαρκέλλα Ζαννίκου, Aurora Lopez‐Rosas, Yu Han, Ting Xiao et al. · 2019 · Proceedings of the National Academy of Sciences
91. Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma
    Zhitao Ying, Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Chen Zhang, Weiping Liu et al. · 2019 · Molecular Therapy — Oncolytics
92. Immune escape: A critical hallmark in solid tumors
    Keywan Mortezaee · 2020 · Life Sciences
93. CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
    Ugo Testa, Elvira Pelosi, Germana Castelli · 2019 · Cancers
94. Bystander T cells in cancer immunology and therapy
    Stefanie L. Meier, Ansuman T. Satpathy, Daniel K. Wells · 2022 · Nature Cancer
95. Trial watch: Peptide-based vaccines in anticancer therapy
    Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan G. Pol, Jitka Palich Fucikova, Radek Špíšek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2018 · OncoImmunology
96. Designing inorganic nanomaterials for vaccines and immunotherapies
    Krystina L. Hess, Igor L. Medintz, Christopher M. Jewell · 2019 · Nano Today
97. A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia
    Qian Zhang, Morgan E. Hresko, Lora K. Picton, Leon Su, Michael J. Hollander, Selene Nuñez-Cruz, Zheng Zhang, Charles‐Antoine Assenmacher, Jonathan T. Sockolosky, K. Christopher García et al. · 2021 · Science Translational Medicine
98. Heterostructural Nanoadjuvant CuSe/CoSe2 for Potentiating Ferroptosis and Photoimmunotherapy through Intratumoral Blocked Lactate Efflux
    Chunzheng Yang, Man Wang, Mengyu Chang, Meng Yuan, Wenying Zhang, Jia Tan, Binbin Ding, Ping’an Ma, Jun Lin · 2023 · Journal of the American Chemical Society
99. Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy
    Dominic Denk, Valentina Petrocelli, Claire Conche, Moritz Wolfgang Drachsler, Paul K. Ziegler, Angela Braun, Alena Kress, Adele M. Nicolas, Kathleen Mohs, Christoph Becker et al. · 2022 · Immunity
100. Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions
     Francesca Arruga, Benjamin Baffour Gyau, Andrea Iannello, Nicoletta Vitale, Tiziana Vaisitti, Silvia Deaglio · 2020 · International Journal of Molecular Sciences